Exelixis reported $38.2M in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
Amgen AMGN:US $ 1884M 1420M
AstraZeneca AZN:LN -1652M 2202M
Bayer BAYN:GR € 85M 2420M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Bristol Myers Squibb BMY:US $ 1546M 491M
Cytokinetics CYTK:US $ -76.09M 14.53M
Dicerna Pharmaceuticals DRNA:US $ -17.07M 23.74M
Eisai 4523:JP Y 4024M 38138M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Exelixis EXEL:US $ 38.2M 57.89M
Genmab GEN:DC DK 890M 584M
Glaxosmithkline GSK:US $ 1168M 227M
Immunogen IMGN:US $ -37.34M 6.6M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Macrogenics MGNX:US $ -52.89M 12.95M
Merk MRK:US $ 4567M 3022M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Moderna Inc MRNA:US 3.33B 553M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Novartis NOVN:VX SF 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Puma Biotechnology PBYI:US $ -44.67M 39.57M
Seattle Genetics SGEN:US $ -293.85M 209.27M
Takeda 4502:JP Y 45965M 154412M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Xencor XNCR:US $ -40.19M 92.44M
YTE INCY:US $ 181.74M 32.28M